Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 3-methoxy-2-oxo PCE​
• MXE

Formulation: A neat solid

Purity: ≥98%

Schedule: IV

• SL 80-0750

Formulation: A crystalline solid

Purity: ≥98%

Schedule: Listed

• NSC 144
• NSC 40929

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• NSC 111388
• NSC 126877
• NSC 631628

Formulation: A neat solid

Purity: ≥98%

• NSC 631646

Formulation: A crystalline solid

Purity: ≥98%

Schedule: IV

• U-33030

Formulation: A neat solid

Purity: ≥98%

Schedule: IV

• CL 284,846

Formulation: A 100 µg/ml or 1 mg/ml solution in methanol

• CL 284,846

Formulation: A crystalline solid

Purity: ≥98%

• Aolan
• Athinazone
• Ethinazone
• NSC 96163

Formulation: A crystalline solid

Purity: ≥98%

Schedule: III

• NSC 30442
• Ro 1-6463

Formulation: A 1 mg/ml solution in acetonitrile

• RP 27267
• (±)-Zopiclone

Formulation: A 1 mg/ml solution in methanol

• SL 80-0750

Formulation: A 1 mg/ml solution in acetonitrile

• N-Methyloxazepam-d₅

Formulation: A 100 µg/ml or 1 mg/ml solution in methanol

• SL 80-0750-d₆

Formulation: A solid

Purity: ≥98%

• Etomidate Impurity B
• NSC 168403
• R 7315

Formulation: A solid

Purity: ≥98%

• Demethoxyyangonin
• NSC 68686
• NSC 112161
• trans-5,6-Dehydrokavain

Formulation: A neat solid

Purity: ≥98%

Schedule: IV

• RP 27267
• (±)-Zopiclone

Formulation: A 1 mg/ml solution in methanol

• CL 284,846

Formulation: A 1 mg/ml solution in methanol

• NSC 111388
• NSC 126877
• NSC 631628

Formulation: A 1 mg/ml solution in acetonitrile

• (±)-Zopiclone-d₄

Formulation: A crystalline solid

Purity: ≥98%

• NSC 74772

Formulation: A solid

Purity: ≥98%

• DL-Pellotine

Formulation: A solid

Purity: ≥98%

Schedule: IV

• SL 80-0750

Formulation: A crystalline solid

Purity: ≥98%

Schedule: Listed

• 2-Acetamidobenzoic Acid
• 2-Carboxyacetanilide
• NSC 4000
• NSC 17831

Formulation: A crystalline solid

Purity: ≥95%

Schedule: II

• 5-Ethyl-5-isopentylbarbituric Acid
• NSC 10815
• NSC 32406
• NSC 120800